Rising Use of GLP-1 Drugs May Be Linked to Rare Pancreatitis Cases, Study Finds
Jin Joong Hwang
Novo Nordisk's diabetes and obesity drug Wegovy (semaglutide) (left) and Eli Lilly's Mounjaro (tirzepatide) / Photo courtesy of Novo Nordisk and Eli Lilly